Crossref
Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?
Hematology Reports · 2009
DOI: 10.4081/hr.2009.e1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology Reports, 2009. Verfasst von Giovanni Martinelli und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Martinelli, G., Soverini, S., Iacobucci, I., Papayannidis, C., Cilloni, D., & Baccarani, M. (2009). Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?. Hematology Reports. https://doi.org/10.4081/hr.2009.e1
Vancouver
Martinelli G, Soverini S, Iacobucci I, Papayannidis C, Cilloni D, Baccarani M. Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?. Hematology Reports. 2009. doi:10.4081/hr.2009.e1
BibTeX
@article{Martinelli2009,
author = {Martinelli, Giovanni and Soverini, Simona and Iacobucci, Ilaria and Papayannidis, Cristina and Cilloni, Daniela and Baccarani, Michele},
title = {Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?},
journal = {Hematology Reports},
year = {2009},
doi = {10.4081/hr.2009.e1}
}
EUVIMED